CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
-7.62%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$897M
AUM Growth
+$897M
(-22%)
Cap. Flow
-$48M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
70.4%
Holding
43
New
2
Increased
7
Reduced
12
Closed
5
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$20.7M |
| 2 |
Structure Therapeutics
GPCR
|
$12.9M |
| 3 |
Pacific Biosciences
PACB
|
$8.65M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$7.88M |
| 5 |
Relay Therapeutics
RLAY
|
$7.78M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$31.2M |
| 2 |
Illumina
ILMN
|
$17.8M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$14.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$12.5M |
| 5 |
Twist Bioscience
TWST
|
$9.21M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sarepta Therapeutics
SRPT
$1.78B
| $122M | 13.55% | 1,010,330 -4,670 | -0.5% | -$566K |
|
2
BioLife Solutions
BLFS
$1.2B
| $107M | 11.89% | 7,780,000 +58,465 | +0.8% | +$807K |
|
|
EQRX
3
DELISTED
EQRx, Inc. Common Stock
EQRX
| $87.8M | 9.71% | 39,527,669 | – | – |
|
|
4
Structure Therapeutics
GPCR
$1.11B
| $62M | 6.86% | 1,258,166 +261,149 | +26% | +$12.9M |
|
|
5
Relay Therapeutics
RLAY
$619M
| $58.2M | 6.44% | 6,923,574 +925,000 | +15% | +$7.78M |
|
6
Revolution Medicines
RVMD
$7.1B
| $50.1M | 5.55% | 1,810,000 | – | – |
|
|
VERV
7
DELISTED
Verve Therapeutics
VERV
| $39.2M | 4.34% | 2,954,710 +594,139 | +25% | +$7.88M |
|
8
Intellia Therapeutics
NTLA
$1.22B
| $37.3M | 4.12% | 1,178,075 -96,925 | -8% | -$3.06M |
|
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $35.4M | 3.92% | 200,000 -80,000 | -29% | -$14.2M |
|
10
Exact Sciences
EXAS
$8.98B
| $31.3M | 3.47% | 459,450 -40,550 | -8% | -$2.77M |
|
|
SLGC
11
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $30.1M | 3.33% | 12,604,275 | – | – |
|
12
Pliant Therapeutics
PLRX
$101M
| $27.3M | 3.03% | 1,577,108 -122,892 | -7% | -$2.13M |
|
13
Denali Therapeutics
DNLI
$2.23B
| $26.8M | 2.97% | 1,300,000 | – | – |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.7M | 2.4% | 498,427 +474,613 | +1,993% | +$20.7M |
|
|
BPMC
15
DELISTED
Blueprint Medicines
BPMC
| $18.7M | 2.06% | 371,378 -248,622 | -40% | -$12.5M |
|
16
Tenaya Therapeutics
TNYA
$184M
| $16.3M | 1.8% | 6,381,377 | – | – |
|
17
Tango Therapeutics
TNGX
$747M
| $14.7M | 1.63% | 1,307,349 +307,349 | +31% | +$3.46M |
|
18
Beam Therapeutics
BEAM
$1.66B
| $13.7M | 1.52% | 570,000 | – | – |
|
19
4D Molecular Therapeutics
FDMT
$288M
| $13.2M | 1.46% | 1,033,811 -36,189 | -3% | -$461K |
|
20
GeneDx Holdings
WGS
$3.72B
| $11.3M | 1.25% | 3,095,511 | – | – |
|
21
AbCellera Biologics
ABCL
$1.25B
| $10.9M | 1.2% | 2,360,129 -159,871 | -6% | -$735K |
|
|
22
Pacific Biosciences
PACB
$393M
| $8.65M | 0.96% | +1,035,859 | New | +$8.65M |
|
23
Avidity Biosciences
RNA
$5.99B
| $7.98M | 0.88% | 1,250,000 +400,000 | +47% | +$2.55M |
|
|
TSVT
24
DELISTED
2seventy bio
TSVT
| $7.93M | 0.88% | 2,023,913 | – | – |
|
25
Century Therapeutics
IPSC
$42.5M
| $6.41M | 0.71% | 3,206,380 | – | – |
|